$Spdr Portfolio High Yield Bond Etf (SPHY.US)$
This security targets high-yield bonds denominated in USD and aims to achieve investment results linked to the ICE BofA US High Yield Index, with the objective of securing High Dividend yield along with diversified investment and stable income.
The total assets under management amount to approximately 7.25 billion USD, with a dividend yield of about 7.86% and an expense ratio of 0.05%.
The current yield of SPHY (SPDR Portfolio High Yield Bond Etf) is approximately 7.76%, and the average minimum yield is 7.52%, providing stable income through monthly distributions.
This security targets high-yield bonds denominated in USD and aims to achieve investment results linked to the ICE BofA US High Yield Index, with the objective of securing High Dividend yield along with diversified investment and stable income.
The total assets under management amount to approximately 7.25 billion USD, with a dividend yield of about 7.86% and an expense ratio of 0.05%.
The current yield of SPHY (SPDR Portfolio High Yield Bond Etf) is approximately 7.76%, and the average minimum yield is 7.52%, providing stable income through monthly distributions.
Translated
1
$Ginkgo Bioworks (DNA.US)$
Today, the stock price of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) fell by more than 6%, likely not due to the stock sale by CFO Mark E. Dmytruk, but related to the company's performance and market reaction.
It seems that DNA recently announced quarterly results that fell short of Financial Estimates, with revenue significantly decreasing compared to the same period last year, and provided disappointing guidance.
Today, the stock price of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) fell by more than 6%, likely not due to the stock sale by CFO Mark E. Dmytruk, but related to the company's performance and market reaction.
It seems that DNA recently announced quarterly results that fell short of Financial Estimates, with revenue significantly decreasing compared to the same period last year, and provided disappointing guidance.
Translated
2
1
$Mitsui Fudosan Logistics Park (3471.JP)$
Continuously increasing dividends over 8 years with large dividends.
It is considered a safe investment due to being traded at low stock price volatility, resulting in low possibility of sharp price increases or decreases in the short term.
Continuously increasing dividends over 8 years with large dividends.
It is considered a safe investment due to being traded at low stock price volatility, resulting in low possibility of sharp price increases or decreases in the short term.
Translated
1
$iFreeETF FANG+ (316A.JP)$
I believe that setting the distribution ratio of VOO, VTI, and FANG+ at this level allows for safe, long-term, diversified, and low-cost investment. What do you think?
• VOO (50%)
• VTI (30%)
• FANG+ (20%)
I believe that setting the distribution ratio of VOO, VTI, and FANG+ at this level allows for safe, long-term, diversified, and low-cost investment. What do you think?
• VOO (50%)
• VTI (30%)
• FANG+ (20%)
Translated
10
1
Translated
5
1
$Daiwa iFree NY Dow Index (0431Q169.MF)$
Daiwa iFree NY Dow Index has received a 5-star high rating from Morningstar, and has several advantages compared to other New York Dow-related ETFs and funds.
The trust fee for iFree NY Dow Index is 0.2475% annually, relatively low cost compared to others in the same category. This is a significant advantage for long-term investments.
This fund has an excellent track record in the past, and its high correlation with the benchmark, the NY Dow, is highly praised. The annual return over 3 years is 19.68%, and over 5 years it is 17.63%, showing stable performance.
The net assets of iFree NY Dow Index exceed 86.7 billion yen, boasting a large scale within the same category. This contributes to high liquidity and operational stability.
This fund is a savings NISA compatible product, suitable for long-term asset formation.
iFree Dow Jones Industrial Average Index can maximize the compound effect by reinvesting dividends.
This fund does not have a currency hedge, so in the event of a depreciation of the yen...
Daiwa iFree NY Dow Index has received a 5-star high rating from Morningstar, and has several advantages compared to other New York Dow-related ETFs and funds.
The trust fee for iFree NY Dow Index is 0.2475% annually, relatively low cost compared to others in the same category. This is a significant advantage for long-term investments.
This fund has an excellent track record in the past, and its high correlation with the benchmark, the NY Dow, is highly praised. The annual return over 3 years is 19.68%, and over 5 years it is 17.63%, showing stable performance.
The net assets of iFree NY Dow Index exceed 86.7 billion yen, boasting a large scale within the same category. This contributes to high liquidity and operational stability.
This fund is a savings NISA compatible product, suitable for long-term asset formation.
iFree Dow Jones Industrial Average Index can maximize the compound effect by reinvesting dividends.
This fund does not have a currency hedge, so in the event of a depreciation of the yen...
Translated
8
5
$Ginkgo Bioworks (DNA.US)$
The research collaboration announcement between Ginkgo Bioworks and Universal Cells may accelerate the development of next-generation cell therapy for cancer.
The US December employment statistics announced on January 5 showed a significant increase of 0.256 million in the number of non-agricultural sector employees, exceeding market Financial Estimates, and the unemployment rate also dropped to 4.1%.
This strong employment statistic widened the view that the pace of the FRB rate cuts would slow down, putting downward pressure on the entire stock market.
I think it is highly likely that the stock price of Ginkgo Bioworks has also been influenced by this market trend and may have declined.
The drop in Ginkgo Bioworks' stock price is believed to be mainly due to the overall market decline trend driven by strong employment statistics, as well as changes in the company's specific financial situation and market valuation.
It is unlikely that the announcement of a research collaboration itself is a direct cause of the stock price drop, rather, it is thought to have a high potential to strengthen the company's technological capabilities and market position in the long term.
The research collaboration announcement between Ginkgo Bioworks and Universal Cells may accelerate the development of next-generation cell therapy for cancer.
The US December employment statistics announced on January 5 showed a significant increase of 0.256 million in the number of non-agricultural sector employees, exceeding market Financial Estimates, and the unemployment rate also dropped to 4.1%.
This strong employment statistic widened the view that the pace of the FRB rate cuts would slow down, putting downward pressure on the entire stock market.
I think it is highly likely that the stock price of Ginkgo Bioworks has also been influenced by this market trend and may have declined.
The drop in Ginkgo Bioworks' stock price is believed to be mainly due to the overall market decline trend driven by strong employment statistics, as well as changes in the company's specific financial situation and market valuation.
It is unlikely that the announcement of a research collaboration itself is a direct cause of the stock price drop, rather, it is thought to have a high potential to strengthen the company's technological capabilities and market position in the long term.
Translated
7
1
1
$Colan Totte (7792.JP)$
On the company's balance sheet, the amount of cash holdings exceeds the total debt, indicating financial stability. Corontte's financial health is excellent.
Corontte's ROE was 27.77% for the last fiscal year ending in September 2024.
It has increased significantly from the previous year.
With ROE exceeding 15%, considered as an excellent capital efficiency, I believe Corontte has achieved very efficient capital efficiency.
It is believed that the maintenance of such a high ROE reflects Colantotte's position as a leading company in the magnetic health gear market and its continuous business growth.
On the company's balance sheet, the amount of cash holdings exceeds the total debt, indicating financial stability. Corontte's financial health is excellent.
Corontte's ROE was 27.77% for the last fiscal year ending in September 2024.
It has increased significantly from the previous year.
With ROE exceeding 15%, considered as an excellent capital efficiency, I believe Corontte has achieved very efficient capital efficiency.
It is believed that the maintenance of such a high ROE reflects Colantotte's position as a leading company in the magnetic health gear market and its continuous business growth.
Translated
$The Kraft Heinz (KHC.US)$
The current dividend yield is 5.30%, and The Kraft Heinz Co is maintaining a high dividend yield, indicating that it is maintaining profitability.
The ability to maintain dividends lies in the stability of free cash flow and the management's willingness to maintain dividends, so I believe that The Kraft Heinz's dividend yield is likely to be maintained.
The Kraft Heinz Co's stock price has recently dropped to a 52-week low of $29.87, I think it's a good opportunity to Buy on the dip.
The Kraft Heinz, also owned by Warren Buffett, has not yet been sold.
The current dividend yield is 5.30%, and The Kraft Heinz Co is maintaining a high dividend yield, indicating that it is maintaining profitability.
The ability to maintain dividends lies in the stability of free cash flow and the management's willingness to maintain dividends, so I believe that The Kraft Heinz's dividend yield is likely to be maintained.
The Kraft Heinz Co's stock price has recently dropped to a 52-week low of $29.87, I think it's a good opportunity to Buy on the dip.
The Kraft Heinz, also owned by Warren Buffett, has not yet been sold.
Translated
4
1
$Ginkgo Bioworks (DNA.US)$
The stock price of Gingko Bioworks Holdings (DNA) is soaring.
Announced a 5-year partnership with Google Cloud, working on developing large-scale language models on Google Cloud's AI platform, which is being recognized and has led to increased investor expectations, resulting in a rise in stock price.
The stock price of Gingko Bioworks Holdings (DNA) is soaring.
Announced a 5-year partnership with Google Cloud, working on developing large-scale language models on Google Cloud's AI platform, which is being recognized and has led to increased investor expectations, resulting in a rise in stock price.
Translated
3
1
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)
アキバのヨッシー OP : When comparing the annual return of SPHY with other ETFs, SPHY's return over the past year is about 11.23%, demonstrating high profitability as a high-yield Bond ETF.
• SPY (S&P 500 linked ETF): The average annual return over the past years is about 7.0%.
• SPYD (high-dividend stocks ETF): The annual return is approximately 5.4%.
Compared to these, SPHY provides a higher return than other ETFs.